Peter R. Breggin

1.3k total citations
76 papers, 862 citations indexed

About

Peter R. Breggin is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, Peter R. Breggin has authored 76 papers receiving a total of 862 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Psychiatry and Mental health, 20 papers in Clinical Psychology and 12 papers in Pharmacology. Recurrent topics in Peter R. Breggin's work include Treatment of Major Depression (12 papers), Electroconvulsive Therapy Studies (11 papers) and Attention Deficit Hyperactivity Disorder (9 papers). Peter R. Breggin is often cited by papers focused on Treatment of Major Depression (12 papers), Electroconvulsive Therapy Studies (11 papers) and Attention Deficit Hyperactivity Disorder (9 papers). Peter R. Breggin collaborates with scholars based in United States and Canada. Peter R. Breggin's co-authors include David Cohen, Kathleen Wheeler, Fred Bemak, Brenda A. LeFrançois, Judith Kegan Gardiner, Peter Krämer, Donald H. Marks, James A. Thorp and Brad Hagen and has published in prestigious journals such as JAMA, American Journal of Psychiatry and Behavioral and Brain Sciences.

In The Last Decade

Peter R. Breggin

68 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter R. Breggin United States 16 327 303 154 149 131 76 862
Massimiliano Aragona Italy 16 366 1.1× 188 0.6× 136 0.9× 100 0.7× 114 0.9× 55 818
Emily Stein United States 4 305 0.9× 294 1.0× 55 0.4× 105 0.7× 70 0.5× 5 807
Andreas Hillert Germany 17 319 1.0× 418 1.4× 153 1.0× 232 1.6× 50 0.4× 81 1.1k
W.A.M. Vollebergh Netherlands 13 557 1.7× 504 1.7× 109 0.7× 292 2.0× 116 0.9× 23 1.2k
Pirjo Saarinen Finland 20 684 2.1× 735 2.4× 155 1.0× 312 2.1× 129 1.0× 33 1.5k
S. M. Channabasavanna India 22 626 1.9× 470 1.6× 146 0.9× 321 2.2× 78 0.6× 82 1.5k
Mordechai Mark Israel 13 435 1.3× 608 2.0× 66 0.4× 146 1.0× 136 1.0× 31 1.0k
Haim Dasberg Israel 17 432 1.3× 189 0.6× 102 0.7× 87 0.6× 36 0.3× 56 828
Margalida Vives Barceló Spain 14 436 1.3× 189 0.6× 142 0.9× 244 1.6× 36 0.3× 61 1.1k
Xiao‐Lan Cao China 17 358 1.1× 444 1.5× 93 0.6× 147 1.0× 48 0.4× 47 956

Countries citing papers authored by Peter R. Breggin

Since Specialization
Citations

This map shows the geographic impact of Peter R. Breggin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter R. Breggin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter R. Breggin more than expected).

Fields of papers citing papers by Peter R. Breggin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter R. Breggin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter R. Breggin. The network helps show where Peter R. Breggin may publish in the future.

Co-authorship network of co-authors of Peter R. Breggin

This figure shows the co-authorship network connecting the top 25 collaborators of Peter R. Breggin. A scholar is included among the top collaborators of Peter R. Breggin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter R. Breggin. Peter R. Breggin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Breggin, Peter R.. (2020). Moving past the vaccine/autism controversy - to examine potential vaccine neurological harms. International Journal of Risk & Safety in Medicine. 32(1). 25–39.
2.
Breggin, Peter R., et al.. (2014). The Utmost Discretion: How Presumed Prudence Leaves Children Susceptible to Electroshock. Children & Society. 28(3). 205–217. 10 indexed citations
3.
Breggin, Peter R.. (2009). Electroshock Forced on Children and Involuntary Adults. Ethical Human Psychology and Psychiatry. 11(2). 80–82. 1 indexed citations
4.
Breggin, Peter R., et al.. (2008). Exposure to SSRI Antidepressants In Utero Causes Birth Defects, Neonatal Withdrawal Symptoms, and Brain Damage. Ethical Human Psychology and Psychiatry. 10(1). 5–9.
5.
Breggin, Peter R.. (2007). Brain Disabling Treatments in Psychiatry: Drugs, Electroshock, and the Psychopharmaceutical Complex. DigitalGeorgetown (Georgetown University Library). 38 indexed citations
6.
Breggin, Peter R.. (2006). How GlaxoSmithKline Suppressed Data on Paxil-Induced Akathisia: Implications for Suicidality and Violence. Ethical Human Psychology and Psychiatry. 8(2). 91–100. 6 indexed citations
7.
Breggin, Peter R.. (2004). Suicidality, violence and mania caused by selective serotonin reuptake inhibitors (SSRIs): A review and analysis. International Journal of Risk & Safety in Medicine. 16(1). 31–49. 55 indexed citations
8.
Breggin, Peter R.. (2004). Recent U.S., Canadian and British regulatory agency actions concerning antidepressant‐induced harm to self and others: A review and analysis. International Journal of Risk & Safety in Medicine. 16(4). 247–259. 4 indexed citations
9.
Breggin, Peter R.. (2001). Fluvoxamine as a cause of stimulation, mania and aggression with a critical analysis of the FDA‐approved label. International Journal of Risk & Safety in Medicine. 14(3-4). 71–86. 9 indexed citations
10.
Breggin, Peter R.. (2000). Reclaiming our children : a healing solution for a nation in crisis. 11 indexed citations
11.
Breggin, Peter R.. (2000). The NIMH multimodal study of treatment for attention‐deficit/hyperactivity disorder: A critical analysis. International Journal of Risk & Safety in Medicine. 13(1). 15–22. 12 indexed citations
12.
Breggin, Peter R. & David Cohen. (1999). Your drug may be your problem : how and why to stop taking psychiatric drugs. 43 indexed citations
13.
Breggin, Peter R.. (1999). The Heart of Being Helpful: Empathy and the Creation of a Healing Presence. Medical Entomology and Zoology. 13 indexed citations
14.
Breggin, Peter R.. (1999). Psychostimulants in the treatment of children diagnosed with ADHD: Risks and mechanism of action. International Journal of Risk & Safety in Medicine. 12(1). 3–35. 16 indexed citations
15.
Breggin, Peter R.. (1998). ANALYSIS OF ADVERSE BEHAVIORAL EFFECTS OF BENZODIAZEPINES WITH A DISCUSSION ON DRAWING SCIENTIFIC CONCLUSIONS FROM THE FDA'S SPONTANEOUS REPORTING SYS TEM. ˜The œJournal of mind and behavior. 19(1). 21–49. 16 indexed citations
16.
Breggin, Peter R.. (1998). Electroshock: scientific, ethical, and political issues. International Journal of Risk & Safety in Medicine. 11(1). 5–40. 28 indexed citations
17.
Breggin, Peter R., et al.. (1994). The war against children. St Martin's Press eBooks. 10 indexed citations
18.
Breggin, Peter R.. (1991). Toxic Psychiatry: Why Therapy, Empathy and Love Must Replace the Drugs, Electroshock, and Biochemical Theories of the "New Psychiatry". DigitalGeorgetown (Georgetown University Library). 69 indexed citations
19.
Breggin, Peter R.. (1973). The second wave.. PubMed. 57(1). 10–3. 5 indexed citations
20.
Breggin, Peter R.. (1965). Sedative-like Effect of Epinephrine. Archives of General Psychiatry. 12(3). 255–255. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026